Edesa Biotech EPS Diluted from Other Gain/Loss (Quarterly) Analysis

Edesa Biotech, Inc. (EDSA)

1.02 +0.02 (+2.51%) USD | NASDAQ | Feb 13, 16:00

1.07 +0.05 (+4.90%) After-Hours: 20:00

View EPS Diluted from Other Gain/Loss (Quarterly) for EDSA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	--
Lexaria Bioscience Corp.	--
Xenon Pharmaceuticals, Inc.	--
ProMIS Neurosciences, Inc.	--